Buprenorphine Hydrochloride Injection, 0.3 mg base/mL, 1 mL Single-dose Carpuject, Sterile Cartridge Unit with Luer Lock, For Intramuscular or Intravenous Use, Rx Only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA. NDC: 0409-2012-03

Class I - Dangerous
💊 Drugs Recalled: May 20, 2024 Pfizer Prescription Drugs Nationwide

What Should You Do?

  1. Check if you have this product:
    Lot#: HJ3965; Exp 2024/09 Lot#: HJ8546; Exp 2024/10
  2. Do not eat it: Even if it looks and smells fine, do not consume this product.
  3. Throw it away or return it: You can return the product to the store for a full refund.
  4. Seek medical attention if needed: If you've consumed this product and feel unwell, contact your doctor immediately.
  5. Report problems: Report any issues to the FDA's Safety Reporting Portal.

⚠️ Emergency: If you experience severe symptoms after consuming this product, call 911 or Poison Control at 1-800-222-1222.

Recall Details

Company:
Pfizer Inc.
Reason for Recall:
Lack of Assurance of Sterility-The potential for incomplete crimp seals.
Classification:
Class I - Dangerous

Dangerous or defective products that predictably could cause serious health problems or death.

Status:
ongoing

Product Information

Full Description:

Buprenorphine Hydrochloride Injection, 0.3 mg base/mL, 1 mL Single-dose Carpuject, Sterile Cartridge Unit with Luer Lock, For Intramuscular or Intravenous Use, Rx Only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA. NDC: 0409-2012-03

Product Codes/Lot Numbers:

Lot#: HJ3965; Exp 2024/09 Lot#: HJ8546; Exp 2024/10

Official Source

Always verify recall information with the official FDA source:

View on FDA.gov

FDA Recall Number: D-0564-2024

Related Recalls